Denis Katz MD

đã tạo một bài báo mới

9 Trong

Precision Neurology 2026 From Syndromes to Signatures: The Strategic Rewiring of CNS Drug Development | #denis Katz medical affairs

Precision Neurology 2026 From Syndromes to Signatures: The Strategic Rewiring of CNS Drug Development

From syndromes to signatures: how precision biomarkers and regulatory strategy are rewiring CNS drug development and reducing late-stage failure.

Giống

Bình luận

Đăng lại

Thay đổi ảnh đại diện của anh ấy

9 Trong

Giống

Bình luận

Đăng lại

Tải thêm bài viết

Nam giới
bài viết 2

08/21/90
Sống ở United States
Nằm ở United States
https://salienceclinical.com/

Về

AAV-mediated delivery of enzymes, neurotransmitter-modulating proteins, or neurotrophic factors has been extensively explored in Parkinson’s disease. While early studies suggested biological activity, several randomized controlled trials failed to meet primary clinical endpoints, highlighting the challenges of placebo effects, target engagement, and disease heterogeneity.

Tập ảnh

(0)

Bạn bè

(0)

Thích

(0)

Các nhóm

(0)

9 Trong

Precision Neurology 2026 From Syndromes to Signatures: The Strategic Rewiring of CNS Drug Development

9 Trong

Ngôn ngữ